Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment
Badrul Islam(Erasmus University Rotterdam), Andreas A. Argyriou(Agios Andreas Hospital), Paola Alberti(University of Milano-Bicocca), Noah Kolb(University of Vermont Medical Center), Nathan P. Staff(Mayo Clinic), Maryam B. Lustberg(Yale Cancer Center)
Cited by 68
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Guillain-Barré syndrome related to COVID-19 infection
|Neurology Neuroimmunology & Neuroinflammation|2020|340
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
|Cancer Management and Research|2014|276